In GBM, the expression levels of both SDF-1 and its receptor correlate positively with tumor grade, with CXCR4 being mainly localized to tumor endothelial cells, which likely use the SDF-1/CXCR4 axis to migrate during angiogenesis [49]. This evidence concerns the gene CXCL12 and glioblastoma.